| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 27,320 | 27,360 | 23.12. | |
| 27,160 | 27,435 | 23.12. |
Zu dieser Aktie sind derzeit keine Informationen verfügbar.
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 23.12.2025 | 17:35:31 | 27,975 | 89 |
| 23.12.2025 | 17:26:34 | 27,950 | 60 |
| 23.12.2025 | 17:13:50 | 27,910 | 1 |
| 23.12.2025 | 17:12:35 | 27,835 | 418 |
| 23.12.2025 | 16:38:52 | 28,500 | 100 |
| 23.12.2025 | 16:35:27 | 28,440 | 42 |
| 23.12.2025 | 16:31:06 | 28,330 | 660 |
| 23.12.2025 | 16:31:06 | 28,330 | 297 |
| 23.12.2025 | 16:26:28 | 28,460 | 110 |
| 23.12.2025 | 16:17:42 | 28,795 | 85 |
| 23.12.2025 | 16:17:42 | 28,790 | 297 |
| 23.12.2025 | 16:15:59 | 28,610 | 200 |
| 23.12.2025 | 16:15:58 | 28,635 | 51 |
| 23.12.2025 | 16:15:58 | 28,615 | 70 |
| 23.12.2025 | 16:15:58 | 28,615 | 100 |
| 23.12.2025 | 16:10:28 | 28,690 | 32 |
| 23.12.2025 | 16:10:28 | 28,690 | 100 |
| 23.12.2025 | 16:08:56 | 28,650 | 360 |
| 23.12.2025 | 16:04:52 | 28,745 | 219 |
| 23.12.2025 | 16:04:23 | 28,750 | 300 |
| Tagesumsatz Xetra | - | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Nvidia Rises, Moderna and Brown-Forman Slump, and More | 20 | Baystreet.ca | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| Mo | What to do After Sandisk, Moderna, and Carnival Soared | 62 | Baystreet.ca | ||
| So | Rivian, Sandisk, And Moderna Are Among the Top 10 Large-Cap Gainers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio? | 28 | Benzinga.com | ||
| 19.12. | Down 80%, Should You Buy the Dip on Moderna? | 111 | The Motley Fool | ||
| 18.12. | CEPI steps in to fund Moderna's pandemic flu jab | 50 | pharmaphorum |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency | GlobeNewswire (Europe) | RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from... ► Artikel lesen | |
| Mi | Sanofi will US-Impfstoffhersteller Dynavax für 2,2 Milliarden Dollar kaufen | dpa-AFX | PARIS (dpa-AFX) - Der Pharmakonzern Sanofi will den US-Impfstoffhersteller Dynavax für gut zwei Milliarden Dollar kaufen. Das Gebot liege bei 15,50 US-Dollar je Aktie in bar, teilten die Franzosen... ► Artikel lesen | |
| Mi | Edgewise Therapeutics Announces Completion of the EDG-7500 CIRRUS-HCM Phase 2 Parts B and C and Favorable Interim Safety Results from the Ongoing Part D Study in Hypertrophic Cardiomyopathy | PR Newswire | - In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver... ► Artikel lesen | |
| Di | Evotec: Tagesgewinner im SDAX und TecDAX am 23. Dezember | RuMaS | ||
| Mi | ImmuCell Corporation: ImmuCell Announces Strategic Focus on First Defense After Receiving an FDA Incomplete Letter for Re-Tain | GlobeNewswire (Europe) | PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell"), an animal health company that develops, manufactures and markets products that improve cattle health... ► Artikel lesen |